The Beatrice Hunter Cancer Research Institute logo
  • Jason Harquail, BSc (with honors thesis)


Dr. Gilles A. Robichaud

Program of Study:

PhD in Life Sciences

Project Title:

Elucidating the Regulation of Pax-5 by miRNAs in Cancer Pathology

Scholarships and/or Awards:

  • CIHR-ICR/FRI Trainee Travel Award (2013)
  • American Association for Cancer Research Annual Meeting –Travel Award from Université de Moncton (2013)
  • BHCRI-CRTP Award (2013-2014)
  • Université de Moncton PhD graduate program Heritage Entrance Excellence Bursary (2012-2013)
  • Fourth Annual BHCRI Cancer Research Conference in Atlantic Canada – Travel Award (2012)
  • Université de Moncton 2nd cycle – Excellence Bursary (2010-2012)
  • Natural Sciences and Engineering Research Council of Canada – Canada Graduate Scholarships Masters (NSERC-CGSM) (2010-2011)
  • Dean’s Mention of Honor (2005-2010)
  • Canadian Breast Cancer Foundation Undergraduate Research Award (2009-2010)
  • Université de Moncton Academic Merit Bursary (2009)
  • Université de Moncton Leadership Award (2008-2009)

Career Aspirations:

Currently in his PhD, Jason was fast-tracked directly from his first year of the MSc program in biochemistry after showing promising preliminary results as well as the drive and motivation to take his research project one step further. After completing his PhD, Jason intends on obtaining a post doctoral fellowship in a leading cancer research center in hopes of developing new knowledge pertaining to cancer progression and diagnosis as well as establishing new collaborations and nourishing existing ones. Ultimately, Jason has set himself a goal of becoming a resourceful, thorough and proficient primary
investigator, leading his own team towards a better understanding of cancer pathology.


Université de Moncton


Sami Benzina*, Jason Harquail*, Stéphanie Jean, Caitlyn Carpenter, Allyson Bos, Christ A.Gray, and Gilles A. Robichaud, Apoptosis-guided fractionation of
Juniperus communis reveals deoxypodophyllotoxin and isocupressic acid as potent breast cancer drugs – in preparation, 2013 (Scientific Paper)

Kevin Cormier, Jason Harquail, Rodney J. Ouellette, Philippe Tessier, Roxann Guerrette and Gilles A. Robichaud, Intracellular expression of inflammatory
proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells – in review, 2013 (Scientific

Jason Harquail*, Sami Benzina* and Gilles A. Robichaud, The Roles of miRNAs in Breast Cancer Processes Leading to Malignancy, Cancer Biomarkers – 2013
(Review paper)

*First co-authors


  • Jason Harquail and Gilles A. Robichaud, MiRNAs 484 and 210 regulate Pax-5 expression and function in breast cancer models, 2013 Canadian Cancer Research
    Conference – November 2013, Toronto, Ontario- Poster
  • Terry Fox Research Institute (TFRI) – Ottawa, 2013 - Poster
  • American Association for Cancer Research (AACR) – Washington, 2013 - Poster



Beatrice Hunter Cancer Research Institute (BHCRI) – Halifax, 2012 - Presentation

Site by: Spectacle Group